Note 8 - Stockholders' Deficit (Details 1) - $ / shares |
12 Months Ended | |
|---|---|---|
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| Equity [Abstract] | ||
| Outstanding, beginning | 106,650 | 106,650 |
| Granted | 382,353 | 0 |
| Forfeited/canceled | (28,256) | 0 |
| Exercised | (239,706) | 0 |
| Outstanding, ending | 221,041 | 106,650 |
| Exercisable, ending | 221,041 | |
| Outstanding, beginning | $ 3.40 | $ 3.40 |
| Granted | 3.40 | 0.00 |
| Forfeited/canceled | 3.40 | 0.00 |
| Exercised | .00 | 0.00 |
| Outstanding, ending | 3.40 | $ 3.40 |
| Exercisable, ending | $ 3.40 | |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|